Can anyone suggest why the FDA are being so slow in their response regards the p3 trials. It always appeared that it would be a clear cut decision to give the go ahead and yet here they are taking a long time to make a decision , given PAR has fast track designation.
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
42.0¢ |
Change
0.020(5.00%) |
Mkt cap ! $166.9M | |||
| Open | High | Low | Value | Volume |
| 40.0¢ | 42.5¢ | 39.5¢ | $228.1K | 550.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 22187 | 41.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 42.0¢ | 13112 | 4 |
View Market Depth
| Last trade - 15.11pm 22/07/2025 (20 minute delay) ? |
| PAR (ASX) Chart |